Storia della carriera di Aaron Foster
Precedenti posizioni note di Aaron Foster
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Baylor College of Medicine | Corporate Officer/Principal | 01/01/2007 | 01/01/2012 |
| BELLICUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/03/2019 | - |
Formazione di Aaron Foster
| University of Puget Sound | Undergraduate Degree |
| The University of Sydney | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Giappone | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Borsa valori
- Insiders
- Aaron Foster
- Esperienza
